Managing hunger effectively whilst on retatrutide involves a combination of practical strategies, realistic expectations, and close communication with your healthcare team
The overall heterogeneity levels were 24.4% (95% uncertainty intervals, 0 and 54.9%) for nonfatal MI (moderate), 11.1% (95% uncertainty intervals, 0 and 48.0%) for nonfatal stroke (low) and 15.8% (95% uncertainty intervals, 0 and 49.9%) for CV death (moderate) (Additional file 1: Table S3)
Why prolonged intermittent fasting is not recommended during GLP-1 therapy With GLP-1 treatment, the appetite is greatly reduced anyway
Track healthcare spending for free
Cognitive behavioural therapy for tinnitus
Trends in FDA FY2024 Inspection-Based Warning Letters, March 7, 2025